Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 92-54-6, N-phenylpiperazine, Phenylpiperazine, Piperazine, 1-phenyl-, 1-phenyl-piperazine, N-phenyldiethylenediamine
Molecular Formula
C10H14N2
Molecular Weight
162.23  g/mol
InChI Key
YZTJYBJCZXZGCT-UHFFFAOYSA-N
FDA UNII
J9225CBI7D

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-phenylpiperazine
2.1.2 InChI
InChI=1S/C10H14N2/c1-2-4-10(5-3-1)12-8-6-11-7-9-12/h1-5,11H,6-9H2
2.1.3 InChI Key
YZTJYBJCZXZGCT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CN(CCN1)C2=CC=CC=C2
2.2 Other Identifiers
2.2.1 UNII
J9225CBI7D
2.3 Synonyms
2.3.1 MeSH Synonyms

1. N-phenylpiperazine

2. Phenylpiperazine

3. Phenylpiperazine Dihydrobromide

4. Phenylpiperazine Dihydrochloride

5. Phenylpiperazine Hydrochloride

6. Phenylpiperazine Monohydrochloride

2.3.2 Depositor-Supplied Synonyms

1. 92-54-6

2. N-phenylpiperazine

3. Phenylpiperazine

4. Piperazine, 1-phenyl-

5. 1-phenyl-piperazine

6. N-phenyldiethylenediamine

7. 4-phenylpiperazine

8. N-phenyl Piperazine

9. 1-phenyl Piperazine

10. Chembl9434

11. J9225cbi7d

12. 1-fenylpiperazin

13. 1-fenylpiperazin [czech]

14. N-phenylpiperazin

15. Ccris 4334

16. Einecs 202-165-6

17. Brn 0132157

18. Unii-j9225cbi7d

19. 1-phenylpiperazinehydrochloride

20. Ai3-26332

21. Phenyl Piperazine

22. Phenyl-piperazine

23. 4-phenylpiperazin

24. N-phenylpiperizine

25. N-phenylpyperazine

26. 1-phenypiperazine

27. 4-phenylpiperizine

28. N-phenyl Piperazin

29. N Phenyl Piperazine

30. N-phenyl-piperazine

31. 4-phenyl Piperazine

32. 4-phenyl-piperazine

33. 1- Phenylpiperazine

34. Mfcd00005957

35. 1-n-phenylpiperazine

36. N'-phenyl-piperazine

37. 1-phenylpiperazine, 99%

38. Ec 202-165-6

39. Dsstox_cid_31644

40. Dsstox_rid_97528

41. Dsstox_gsid_57855

42. Schembl24889

43. Phenylpiperazine, 1-

44. 5-23-01-00160 (beilstein Handbook Reference)

45. Bidd:gt0830

46. Dtxsid8057855

47. Zinc120271

48. Act03613

49. Bcp22010

50. 1-phenylpiperazine 63921-23-3

51. Tox21_113878

52. Bbl027548

53. Bdbm50001898

54. Stl282711

55. Akos000119106

56. Ab00546

57. Ac-2107

58. Am81359

59. Cs-w019986

60. Lf-0549

61. Cas-92-54-6

62. Ncgc00253765-01

63. Db-027446

64. A4752

65. Bb 0295926

66. Ft-0631450

67. P0980

68. Levodropropizine Impurity B [ep Impurity]

69. Ae-641/30105013

70. Sr-01000944921

71. Q-100891

72. Q4862383

73. Sr-01000944921-1

74. F2190-0343

75. Levodropropizine Impurity B, European Pharmacopoeia (ep) Reference Standard

76. Vu9

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 162.23 g/mol
Molecular Formula C10H14N2
XLogP31.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass162.115698455 g/mol
Monoisotopic Mass162.115698455 g/mol
Topological Polar Surface Area15.3 Ų
Heavy Atom Count12
Formal Charge0
Complexity124
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Adrenergic alpha-Antagonists

Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)


Psychotropic Drugs

A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)